Nov 08, 2020
Immutep’s Phase II TACTI-002 Study Reports Encouraging Data at SITC
Immutep Announces Australian Patent Grant for IMP701 Antibody
Nov 01, 2020
Immutep’s TACTI-002 Data To Be Presented At Society For Immunotherapy Of Cancer 2020 Annual Meeting
Oct 29, 2020
Immutep to Collaborate with LabCorp to Develop Oncology Services and Products
Oct 22, 2020
Immutep Announces the Start of an Investigator-Initiated Phase II Study in COVID-19 Patients
Oct 21, 2020
Immutep Granted European Patent for IMP761
Immutep Activities Report for the First Quarter of Fiscal Year 2021
Oct 18, 2020
Immutep to Present AIPAC Overall Survival Data at the San Antonio Breast Cancer Symposium 2020
Sep 16, 2020
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study
Immutep Reports Improving Results from INSIGHT-004 Trial
Aug 30, 2020
Immutep and Monash University Receive Grant Funding for LAG-3 Project
Aug 25, 2020
New Data From Immutep’s Efti To Be Presented At ESMO
